
GC73811
SOS1/EGFR-IN-1
Also known as N-[(1R)-1-(3-fluorophenyl)ethyl]-7-methoxy-6-(oxan-4-yloxy)quinazolin-4-amine
SOS1/EGFR-IN-1 (compound SE-9) is a dual-target inhibitor for the prostate cancer
ChemicalCAS2956724-20-0MW397.44FormulaC22H24FN3O3
- CAS number
- 2956724-20-0
- Molecular weight
- 397.44
- Formula
- C22H24FN3O3
- Solubility
- DMSO : 100 mg/mL (251·61 mM; ultrasonic and warming and heat to 60°C)
- InChIKey
- ZHVASSKARGGGPC-CQSZACIVSA-N
- Catalogue number
- GC73811
- Brand
- GLPBIO
Computed properties PubChem CID 171714276 · XLogP 4.2 · TPSA 65.5 Ų · H-bond donors 1
- XLogP
- 4.2
- TPSA
- 65.5 Ų
- H-bond donors
- 1
- H-bond acceptors
- 7
- Rotatable bonds
- 6
- Heavy atoms
- 29
SMILES C[C@H](C1=CC(=CC=C1)F)NC2=NC=NC3=CC(=C(C=C32)OC4CCOCC4)OC
Computed descriptors from PubChem (CID 171714276), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il